Furthermore, the exclusion of the EpCAM+/CD45+ cell subpopulation from the depleted cell fraction will not preserve the original MPE tumor heterogeneity and will fail to reliably reflect its drug sensitivity. The gene discussed is PTPRC; the disease is neoplasm.